Cardiovascular safety of NSAIDs.
作者信息
Harbin Megan, Turgeon Ricky D, Kolber Michael R
出版信息
Can Fam Physician. 2014 Mar;60(3):e166.
Abstract
摘要
相似文献
1
Cardiovascular safety of NSAIDs.
Can Fam Physician. 2014 Mar;60(3):e166.
2
NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
Prescrire Int. 2016 Jan;25(167):14-6.
3
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
Ann Rheum Dis. 2007 Jun;66(6):764-70. doi: 10.1136/ard.2006.066001. Epub 2007 Apr 5.
4
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Circ Cardiovasc Qual Outcomes. 2009 May;2(3):155-63. doi: 10.1161/CIRCOUTCOMES.108.805689. Epub 2009 May 5.
5
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13.
6
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int. 2007 Dec;16(92):223-7.
7
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
JAMA. 2006 Oct 4;296(13):1633-44. doi: 10.1001/jama.296.13.jrv60011. Epub 2006 Sep 12.
8
Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
J Cardiovasc Pharmacol Ther. 2008 Mar;13(1):41-50. doi: 10.1177/1074248407312990.
9
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27.
10
Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
Br J Clin Pharmacol. 2018 May;84(5):1045-1056. doi: 10.1111/bcp.13537. Epub 2018 Mar 13.
引用本文的文献
1
The Singapore Experience With Uncontrolled Gout: Unmet Needs in the Management of Patients.
Cureus. 2023 Mar 25;15(3):e36682. doi: 10.7759/cureus.36682. eCollection 2023 Mar.
2
Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain.
Indian J Palliat Care. 2019 Jan-Mar;25(1):164-165. doi: 10.4103/IJPC.IJPC_143_18.
3
Tramadol: a valuable treatment for pain in Southeast Asian countries.
J Pain Res. 2018 Oct 24;11:2567-2575. doi: 10.2147/JPR.S162296. eCollection 2018.
4
Symptom management challenges in heart failure: pharmacotherapy considerations.
Heart Fail Rev. 2017 Sep;22(5):525-534. doi: 10.1007/s10741-017-9632-5.
本文引用的文献
1
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.
Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.
2
Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.
PLoS Med. 2013;10(2):e1001388. doi: 10.1371/journal.pmed.1001388. Epub 2013 Feb 12.
3
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000.
4
Topical NSAIDs for chronic musculoskeletal pain in adults.
Cochrane Database Syst Rev. 2012 Sep 12;9(9):CD007400. doi: 10.1002/14651858.CD007400.pub2.
5
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. doi: 10.1002/acr.21596.
6
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.
PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27.
7
Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):876-80. doi: 10.1097/MEG.0b013e328349de81.
8
Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis.
J Pain Res. 2011;4:159-67. doi: 10.2147/JPR.S20965. Epub 2011 Jun 3.
9
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.
BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086.
10
Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers.
J Clin Pharmacol. 2010 Jan;50(1):50-61. doi: 10.1177/0091270009336234. Epub 2009 Oct 19.
Zotero 插件